Sony Pixel Power calrec Sony

May 14, 2019

15/05/2019

FDA approves phase 1/2 clinical trial with ABX196 in patients with liver cancer ABX196 to be tested in combination with checkpoint inhibitor nivolumab to treat hepatocellular carcinoma

May 14, 2019

LA JOLLA, CA The U.S. Food and Drug Administration has approved an investigational new drug (IND) application for a phase 1/2 clinical trial of ABX196, a liver cancer therapy developed in the laboratory of Scripps Research Professor Luc Teyton, MD, PhD, and licensed to French pharmaceutical company Abivax.

The FDA approval allows Abivax testing of ABX196 in patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. ABX196 showed potent efficacy against HCC in preclinical testing.

The translation of basic research discoveries to the clinic is the greatest achievement we can hope for as clinician scientists. says Teyton, who is also a member of Abivax's Scientific Advisory Board. The use of ABX196 in the context of immunotherapy has been shown to be beneficial in multiple animal models of cancer, but the results with hepatocellular carcinoma are spectacular. We are looking forward to impacting the disease in patients, especially given the limitations of current therapies.

The open IND allows Abivax to test ABX196 in combination with nivolumab (Opdivo, Bristol-Myers Squibb), a checkpoint inhibitor, in a first phase 1/2 clinical trial to treat patients with HCC. The initial dose-escalation phase of the study will be conducted at the Scripps MD Anderson Cancer Center in San Diego, California, USA; additional leading cancer centers in the U.S. will be involved in the subsequent expansion phase of the study. The first patient is expected to be enrolled this summer.

We are thrilled to have been given the green light by FDA for our U.S. study. says Hartmut J. Ehrlich, MD, chief executive officer of Abivax. This open IND allows Abivax, in collaboration with leading key opinion leaders at internationally renowned U.S. cancer centers of excellence, to explore the clinical potential of our iNKT agonist ABX196 to broaden and potentiate the activity of the checkpoint inhibitor nivolumab. Based on its unique mechanism of action and exciting preclinical data in several cancer models, we believe ABX196 is a promising immunotherapeutic product candidate for patients with liver cancer that may also have potential in other cancers.

ABX196 is a synthetic glycolipid agonist of invariant natural killer T cells (iNKT) in a liposomal formulation. A phase 1 clinical trial conducted by Abivax in healthy volunteers has been completed and demonstrated safety and tolerability as well as a potent activation of iNKT cells. ABX196, both alone and in combination with a checkpoint inhibitor, showed a statistically highly significant therapeutic effect in reducing tumor growth as measured by MRI and increasing survival in mice with HCC. Abivax holds exclusive rights to ABX196 from Scripps Research, the University of Chicago, and Brigham Young University.

Despite the recent introduction of checkpoint inhibitors, hepatocellular carcinoma continues to be a substantial therapeutic challenge, as only about 20 percent of the treated patients show a response to these new drugs says Darren Sigal, MD, program director of GI Oncology at Scripps Clinic and Scripps MD Anderson Cancer Center in San Diego, and principal investigator of the study. While checkpoint inhibitors block a do not attack me' signal on cancer cells, ABX196 activates iNKT cells, a subpopulation of lymphocytes that is critical for mounting an effective immune response. The synergy between these two molecules carries substantial promise for improved outcomes for patients with this deadly cancer.

Checkpoint inhibitors like nivolumab are a leading class of therapeutic monoclonal antibodies that block certain endogenous proteins (PD-1/PDL-1) made by immune cells, such as T cells, as well as some cancer cells. These proteins effectively hijack the immune system, causing it to keep immune responses in check and preventing T cells from killing cancer cells. When these proteins are blocked, the brakes on the immune system are released and T cells are able to kill cancer cells much more efficiently. In some cancers, treatment with checkpoint inhibitors has been highly efficacious. However, due to the tumor micro-environment in other cancers, such as HCC, checkpoint inhibitors can have difficulties exerting their effects. ABX196 is intended as a drug that will potentiate the efficacy of checkpoint inhibitors by activating iNKT cells to kill tumor cells.

HCC is the most common form (75 to 90 percent) of primary liver cancer in adults. It typically occurs in the setting of chronic liver inflammation and/or cirrhosis and is closely linked to chronic viral infection such as hepatitis B or C, exposure to toxins such as alcohol, and to certain diseases such as non-alcoholic steatohepatitis (NASH).

The incidence of and deaths related to HCC are increasing in the United States and globally due to hepatitis B and C virus infections, as well as NASH. Prevalence data from 2018 show a total of 79,000 cases of HCC in the U.S. and G5 Europe (Germany, France, Italy, Spain and the UK), with 67,000 new cases, and a total of 260,000 cases in China with 338,000 new cases. Globally, there were 841,000 new cases of liver cancer (ranking it sixth of all reported cancers) and 782,000 fatalities (ranking it fourth) in 2018.

Currently, the American Cancer Society reports five-year survival rates in the U.S. of 31 percent for localized HCC, 11 percent for regional, and 2 percent for distant or metastatic, indicating a clear unmet medical need for improved therapies for HCC.

Cancer Immunology & Microbiology Teyton, Luc
LINK: https://www.scripps.edu/news-and-events/press-room/2019/20190514-teyto...
See more stories from scripps

Most recent headlines

05/01/2027

Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be demoed at CES 2026

Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...

04/08/2026

Dalet Announces Commercial Availability of Dalia, Bringing Media-Aware Agentic AI to Enterprise Productions

Dalet, a leading technology and service provider for media-rich organizations, t...

04/07/2026

Detective Conan: Fallen Angel of the Highway Opens in Dolby Cinemas Across Japan, Presented in Dolby Atmos and Dolby ...

April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...

01/06/2026

Dolby Sets the New Standard for Premium Entertainment at CES 2026

January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026 Throughout the week, Dolby brings to life the latest innovatio...

02/05/2026

Dalet Flex LTS Delivers Smarter Search, Faster Editing, and an AI-Ready Foundation for Modern Media

Dalet, a leading technology and service provider for media-rich organizations, t...

01/05/2026

NBCUniversal's Peacock to Be First Streamer to Integrate Dolby's Full Suite of Premium Picture and Sound Innovations

January 5 2026, 18:30 (PST) NBCUniversal's Peacock to Be First Streamer to ...

08/04/2026

SVG College Sports Media Awards 2026: Entry Deadline is Monday, April 13

The deadline to enter the 18th Annual SVG College Sports Media Awards in association with NACDA is rapidly approaching! Submit your entries to this year's c...

08/04/2026

SVG Campus Shot Callers: Trever Sheets, Senior Director, ACC Network, Virginia Tech

The Pittsburgh product helps lead more than 100 annual ESPN broadcasts as part o...

08/04/2026

SVG Sit-Down: Harmonic's Jean Macher on Turning Live Sports Content Into a Smarter Monetization Engine

Dynamic ad insertion, AI-based technologies, programmatic advertising are some o...

08/04/2026

Announcing the 2026 Fellows for the Sundance Institute Cultural Impact Residency on Sundance Collab

Seven Fellows Selected for Second Year of Residency in Honor of Social Justice L...

08/04/2026

From Tokyo to the World: Watch Bad Bunny's Billions Club Live Concert on Spotify

On March 7, Bad Bunny made history with his first-ever performance in Asia, taki...

08/04/2026

De Tokio para el mundo: Mira el concierto Billions Club Live de Bad Bunny en Spotify

El 7 de marzo, Bad Bunny hizo historia con su primera presentaci n en Asia, subi...

08/04/2026

Tube Lab from Fuse Audio Labs

New channel strip plug-in revealed The latest plug-in to be added to the Fuse Audio Labs line-up emulates a selection of vintage hardware units, combining c...

08/04/2026

Blue Cat Audio release Axiom 2.3

Guitar & bass multi-effects software overhauled Blue Cat Audio's flagship guitar and bass multi-effects software has recently received a significant upd...

08/04/2026

Merging Technologies launch Pyramix 16

PanNoir mixer integration, Dolby Atmos Renderer & more Merging Technologies have just launched Pyramix 16, the latest major update to their renowned DAW sof...

08/04/2026

Updating QUARTZ Router Module Firmware Over-The-Air

Applicable Products Part number Description QUARTZ-22-LTE (EU) Dual Port Dual SIM LTE Router (EU) QUARTZ-COMPACT-11-LTE (EU) Single Port Compact LTE ...

08/04/2026

YEP September 2025 Newsletter (2)

The September 19, 2025 YEP Newsletter highlights a group visit to the Academy Museum of Motion Pictures, where participants explored exhibits showcasing the art...

08/04/2026

Proven On Orbit: L3Harris Congratulates Missile Defense Agency for Receiving Top Defense Honor for HBTSS

The L3Harris HBTSS satellite is proven on orbit, successfully demonstrating trac...

08/04/2026

From Earth to Mars: Resilient Communications Powering the Space Economy

Image Credit: NASA. Artist rendering of a space communications satellite in orbit, representative of the resilient, multiband infrastructure supporting mission ...

08/04/2026

Precision in Practice: Flight Test Confirms Key Air-to-Air Capabilities

Latest evaluation validates image quality, Inertial Navigation System performance and long-range tracking in operational flight conditions....

08/04/2026

Gen Alpha Leads Shift to AI-Powered Entertainment Search, Discovery and Recommendations

New Gracenote study finds behavioral change well underway, but trust in AI-gener...

08/04/2026

Media Links to Focus on IP Transport Solutions at 2026 NAB Show

Share Copy link Facebook X Linkedin Bluesky Email...

08/04/2026

Telestream and Mimir Integration Facilitates Real-Time Pr...

Integration eliminates ingest bottlenecks by ensuring content is immediately usable across cloud and hybrid editorial workflows. See it at NAB 2026. Nevada Cit...

08/04/2026

Dalet Announces Commercial Availability of Dalia Bringing...

Dalet, a leading technology and service provider for media-rich organizations, today announced the commercial availability of Dalia, its media-aware, agentic AI...

08/04/2026

Synamedia unveils Senza Ignite to transform deployed devi...

Leading video software provider Synamedia today announced Senza Ignite, a cloud-based platform that transforms existing connected devices through a single firmw...

08/04/2026

Appear works with Corus to transform national news contri...

Modernised architecture increases operational control and agility, while reducing cost and simplifying nationwide media transport across affiliates and news bur...

08/04/2026

LynTec to Showcase High Density Power Control Solutions f...

Company to Feature DMX Dual Relay, High-Density 48-Channel Relay Panels, and New Private Label Power Program LynTec, a leading manufacturer of innovative ele...

08/04/2026

BCE integrates BCNEXXT Vipe to power cloud playout in Med...

Broadcasting Center Europe (BCE), a European media technology and services partner, today announces a technology partnership with BCNEXXT, a Netherlands-based c...

08/04/2026

Encompass Strengthens Global Media Operations with Expans...

Encompass Digital Media today announced the expansion of its Master Control Room (MCR) facility in Riga, Latvia, establishing it as one of the most advanced and...

08/04/2026

Synamedia lights up Las Vegas with innovations that will...

Leading video solutions provider Synamedia is back at The 2026 NAB Show with innovations that connect tomorrows audiences today. On display will be a range of t...

08/04/2026

COW Jobs: Director Needed for WWII Indie Docudrama

COW Jobs: Director Needed for WWII Indie Docudrama Brie Clayton April 8, 2026 0 Comments Director Needed for WWII Indie Docudrama March 17, 2026COW ...

08/04/2026

ESPN Expands Global Reach on Disney+

Share Copy link Facebook X Linkedin Bluesky Email...

08/04/2026

Broadcast Industry Initiatives Promise To Speed Adoption of ST 2110

Share Copy link Facebook X Linkedin Bluesky Email...

08/04/2026

Remembering Television's Role in the U.S. Bicentennial

Share Copy link Facebook X Linkedin Bluesky Email...

08/04/2026

Synamedia Unveils AI by Quortex

Share Copy link Facebook X Linkedin Bluesky Email...

08/04/2026

Carrie Healey Joins NAB as Vice President of Communications

Share Copy link Facebook X Linkedin Bluesky Email...

08/04/2026

Amagi Launches Newspulse

Share Copy link Facebook X Linkedin Bluesky Email...

08/04/2026

Marshall Electronics Unveils CV376 NDI HX3 HDMI POV Camer...

Marshall Electronics introduces its latest POV camera with the new CV376 Compact NDI |HX3 HDMI POV Camera at NAB 2026 (Booth C8339). Designed for versatile 4K c...

08/04/2026

Zixi Showcases Interoperable Live Video Workflows and Sat...

Zixi, a leader in live video delivery and workflow orchestration, enables interoperable live video workflows across multi-vendor environments, helping broadcast...

08/04/2026

Official trailer released for Sky Original action thriller Prisoner, starring Tahar Rahim and Izuka Hoyle

All episodes available on Thursday 30 April on Sky Atlantic and NOWWednesday 8 A...

08/04/2026

Agent from Above' Celebrates Divine Ascent to Global Ranking With Exclusive Cast and Behind-The-Scenes Photos

Back to All News Agent from Above' Celebrates Divine Ascent to Global Rank...

08/04/2026

Official Poster Revealed for 'My Two Cents,' the New Animated Series Created, Written and Directed by Zerocalcare

Back to All News Official Poster Revealed for My Two Cents, the New Animated Se...

08/04/2026

Champions Awards 2026 Finalists & Northern Marketing Festival

ICG is gearing up for a busy day on 14th May in Manchester. First up, we'll be joining the Northern Marketing Festival as one of the event's marketing ...

08/04/2026

How DPA solutions keep the Teatro Coln sounding like itself

The Teatro Col n in Buenos Aires is not a venue that tolerates compromise. Built in 1908 and routinely ranked among the worlds finest concert halls, it has an a...

08/04/2026

Kathryn Thomas questions if we can be Young Forever in new RT documentary

Young Forever: The Death of Ageing? airs Monday 13 April and 20 April on RT One and RT Player Around the world, the race to beat ageing is on. From cutting ...

08/04/2026

April 07, 2026

Scripps Research scientists uncover new mechanism cancer cells use to survive DNA damage Discovery reshapes understanding of how tumor cells repair broken DNA, ...

07/04/2026

NAB 2026: Ikegami USA To Launch Two New Viewfinders, Refine UHD Cameras

Ikegami USA will launch a refinement to the UHK-X700 and UHK-X750 3-CMOS -in. UHD cameras in the UNICAM XE series plus two new 7-in. viewfinders at NAB 2026 in...

07/04/2026

NAB 2026: NAB Leadership Foundation to Host Technology Students Career Mixer

The NAB Leadership Foundation and NAB PILOT will host a career mixer for technology students at NAB Show 2026 on April 18, 5-6:30 p.m., North Hall, Room N225/22...

07/04/2026

Survey: AVoIP Adoption Accelerating, With Interoperability and Security as Key Drivers

Audinate Group Limited and Futuresource Consulting have published results from a...

07/04/2026

NAB 2026: Eluvio Announces Commercial Availability of Content Fabric Bucharest Release

Eluvio has announced the commercial availability of its Content Fabric Bucharest...